Page last updated: 2024-10-24

cefuroxime and Immunologic Deficiency Syndromes

cefuroxime has been researched along with Immunologic Deficiency Syndromes in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rödjer, S1
Alestig, K1
Bergmark, J1
Bergström, T1
Hultberg, B1
Jagenburg, R1
Olaisson, L1
Trollfors, B1
Westin, J1

Trials

1 trial available for cefuroxime and Immunologic Deficiency Syndromes

ArticleYear
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:1

    Topics: Adult; Aged; Ceftazidime; Cefuroxime; Female; Humans; Immunologic Deficiency Syndromes; Kidney; Kidn

1987